ATE253931T1 - High density lipoprotein zur bekämpfung von organdysfunktion infolge hämorrhagischem schocks - Google Patents

High density lipoprotein zur bekämpfung von organdysfunktion infolge hämorrhagischem schocks

Info

Publication number
ATE253931T1
ATE253931T1 AT00956651T AT00956651T ATE253931T1 AT E253931 T1 ATE253931 T1 AT E253931T1 AT 00956651 T AT00956651 T AT 00956651T AT 00956651 T AT00956651 T AT 00956651T AT E253931 T1 ATE253931 T1 AT E253931T1
Authority
AT
Austria
Prior art keywords
high density
density lipoprotein
combat
result
hemorrhagic shock
Prior art date
Application number
AT00956651T
Other languages
English (en)
Inventor
Gillian Cockerill
Norman Miller
Christoph Thiemermann
Centre Sci
Michelle Macdonald
Original Assignee
Queen Mary & Westfield College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Queen Mary & Westfield College filed Critical Queen Mary & Westfield College
Application granted granted Critical
Publication of ATE253931T1 publication Critical patent/ATE253931T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT00956651T 1999-08-19 2000-08-16 High density lipoprotein zur bekämpfung von organdysfunktion infolge hämorrhagischem schocks ATE253931T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9919713.9A GB9919713D0 (en) 1999-08-19 1999-08-19 New medical use of high density lipoprotein
PCT/GB2000/003182 WO2001013939A1 (en) 1999-08-19 2000-08-16 High density lipoprotein against organ dysfunction following haemorrhagic shock

Publications (1)

Publication Number Publication Date
ATE253931T1 true ATE253931T1 (de) 2003-11-15

Family

ID=10859485

Family Applications (2)

Application Number Title Priority Date Filing Date
AT00956651T ATE253931T1 (de) 1999-08-19 2000-08-16 High density lipoprotein zur bekämpfung von organdysfunktion infolge hämorrhagischem schocks
AT03076918T ATE397454T1 (de) 1999-08-19 2000-08-16 High density lipoprotein zur bekämpfung von organdysfunktion infolge eines hämorrhagischen schocks

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT03076918T ATE397454T1 (de) 1999-08-19 2000-08-16 High density lipoprotein zur bekämpfung von organdysfunktion infolge eines hämorrhagischen schocks

Country Status (10)

Country Link
US (1) US6998388B1 (de)
EP (2) EP1369124B1 (de)
AT (2) ATE253931T1 (de)
AU (1) AU779578B2 (de)
CA (1) CA2376260C (de)
DE (2) DE60006548T2 (de)
DK (1) DK1210105T3 (de)
ES (2) ES2209961T3 (de)
GB (1) GB9919713D0 (de)
WO (1) WO2001013939A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10035352A1 (de) 2000-07-20 2002-01-31 Zlb Bioplasma Ag Bern Verfahren zur Behandlung von instabiler Angina pectoris
US20040266660A1 (en) * 2001-08-20 2004-12-30 Alphonse Hubsch Hdl for the treatment of stroke and other ischemic conditions
EP1285662A1 (de) * 2001-08-20 2003-02-26 ZLB Bioplasma AG Rekonstituiertes High-Density -Lipoprotein zur Behandlung von Schlaganfällen und Ischämiezuständen
WO2005068020A1 (en) * 2004-01-02 2005-07-28 Advanced Cardiovascular Systems, Inc. High-density lipoprotein coated medical devices
US7759315B2 (en) * 2005-03-09 2010-07-20 Csl Behring Ag Treatment of inflammatory conditions of the intestine
US8206750B2 (en) 2005-03-24 2012-06-26 Cerenis Therapeutics Holding S.A. Charged lipoprotein complexes and their uses
US7956035B2 (en) 2007-03-01 2011-06-07 Csl Limited Treatment of endothelial dysfunction in diabetic patients
WO2010057203A2 (en) 2008-11-17 2010-05-20 The Board Of Regents Of The University Of Texas System Hdl particles for delivery of nucleic acids
DK2767546T3 (en) 2011-02-07 2019-02-04 Cerenis Therapeutics Holding Sa Lipoprotein complexes and their preparation and uses
KR20170003611A (ko) 2014-05-02 2017-01-09 세레니스 쎄라퓨틱스 홀딩 에스에이 Ｈｄｌ 요법 마커
US20160346219A1 (en) 2015-06-01 2016-12-01 Autotelic Llc Phospholipid-coated therapeutic agent nanoparticles and related methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08198406A (ja) 1995-01-20 1996-08-06 Hitachi Ltd 自動倉庫設備
CA2229140A1 (en) * 1995-08-17 1997-02-27 Protein Design Labs, Inc. Anti-selectin antibodies for prevention of multiple organ failure and acute organ damage
DE19547648A1 (de) * 1995-12-20 1997-06-26 Hoechst Ag Zubereitung, enthaltend High Density Lipoproteine und Crotonsäureamidderivate
JPH1025248A (ja) * 1996-07-08 1998-01-27 Chemo Sero Therapeut Res Inst 抗血管リモデリング剤

Also Published As

Publication number Publication date
ES2307869T3 (es) 2008-12-01
ES2209961T3 (es) 2004-07-01
DE60006548D1 (de) 2003-12-18
EP1369124B1 (de) 2008-06-04
ATE397454T1 (de) 2008-06-15
AU779578B2 (en) 2005-01-27
DK1210105T3 (da) 2004-03-22
GB9919713D0 (en) 1999-10-20
CA2376260A1 (en) 2001-03-01
AU6852500A (en) 2001-03-19
EP1369124A1 (de) 2003-12-10
EP1210105B1 (de) 2003-11-12
CA2376260C (en) 2010-09-28
WO2001013939A1 (en) 2001-03-01
DE60039130D1 (de) 2008-07-17
EP1210105A1 (de) 2002-06-05
DE60006548T2 (de) 2004-09-23
US6998388B1 (en) 2006-02-14

Similar Documents

Publication Publication Date Title
CO5700767A2 (es) Procedimiento de tratamiento de rechazo de transplantes
ATE253931T1 (de) High density lipoprotein zur bekämpfung von organdysfunktion infolge hämorrhagischem schocks
AR028296A1 (es) Metodos sinergisticos y composiciones para el tratamiento del cancer
DE60335244D1 (de) Behandlung von verletzungen des zentralen nervensystems
PT907652E (pt) Compostos e processos imunossupressores
EA200500399A1 (ru) Ненуклеозидные ингибиторы обратной транскриптазы
TR200000374T2 (tr) Akut akciğer harabiyeti ve fibrozitinin alfavbeta6 antagonistleriyle tedavisi.
MY147643A (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
WO2005049000A3 (en) Treatment of phenylketonurias with bh4
NO20092417L (no) Kombinasjon av IAP-inhibitorer og FLT3-inhibitorer
ATE531419T1 (de) Vorrichtung zur verabreichung von therapeutischen mitteln
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
FR2765483B1 (fr) Medicament destine a traiter les dysfonctions erectiles
ZA200201408B (en) Use of docetaxel for treating hepatocellular carcinoma.
CL2004000877A1 (es) Combinacion farmaceutica que comprende 8a) melatonina y agonistas de la melatonina, y nicotina y agonistas receptores de nicotina; kit farmaceutico, y; uso en el tratamiento de insomnio, dificultades cognitivas y dificultades de memoria; kit farmaceu
WO2003063782A3 (en) Kappa-pviia-related conotoxins as organ protectants
WO2002024181A3 (en) The use of melatonin for induction of general anesthesia
MXPA05009640A (es) Tratamiento de condiciones intestinales con n-2,3,3-tetrametilbiciclo [2.2.1] heptan-3-amina.
EP1539132A4 (de) Verwendung von 2,3 alkylcarbonyloxybenzosäuren, ihre derivate und analoga bei der behandlung von gewebe- und zellfunktionsschäden und verletzungen in säugetieren
DE60109594D1 (de) R-eliprodil zur behandlung von glaucoma
WO2001068066A3 (en) A composition comprising camptothecin or a camptothecin derivative and an alkylating agent for the treatment of cancer
ZA200209835B (en) Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or anti-metabolites.
WO2006053322A3 (en) Compositions and methods for inferring an adverse effect in response to a drug treatment
AR028458A1 (es) Un estuche de combinacion usado en el tratamiento del paludismo
KR100348888B1 (en) Method for relieving violence and spare diet of estrous deer and method for promoting growth of antlers thereof

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1210105

Country of ref document: EP

EEIH Change in the person of patent owner
EEFA Change of the company name